1. Introduction
Hepatocellular carcinoma (HCC) is one of the most common
malignancies throughoutthe world with a high incidence and mortality,
which is often diagnosed at an advanced stage [1,2].Although
surgical managements or non-surgical therapeutic modalities have
been employed, HCC is rarely curative. Currently, chemotherapy
is one of the important treatment methods, but the side effects
are difficult to tolerate, and as a result, searching new compounds
withbetter effectiveness and lower toxicityhave receivedmore and
more attentions as a potential origin of new therapeutic anti-tumor
drugs for HCC patients [3,4].